Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma
Abstract High-risk neuroblastoma (HR-NB) has a significantly lower survival rate compared to low- and intermediate-risk NB (LIR-NB) due to the lack of risk classification diagnostic models and effective therapeutic targets. The present study aims to characterize the differences between neuroblastoma...
Main Authors: | Bang Du, Fei Zhang, Qiumei Zhou, Weyland Cheng, Zhidan Yu, Lifeng Li, Jianwei Yang, Xianwei Zhang, Chongchen Zhou, Wancun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43988-w |
Similar Items
-
Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma
by: Wancun Zhang, et al.
Published: (2024-01-01) -
Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma
by: Bang Du, et al.
Published: (2024-08-01) -
Biliary atresia and cholestasis plasma non-targeted metabolomics unravels perturbed metabolic pathways and unveils a diagnostic model for biliary atresia
by: Bang Du, et al.
Published: (2024-07-01) -
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
by: Sisi Gong, et al.
Published: (2024-11-01) -
Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis
by: Wenhao Chen, et al.
Published: (2024-04-01)